The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Ocular Therapeutix, Inc. Investors and Encourages Investors to Contact the Firm

BENSALEM, Pa.--()--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Ocular Therapeutix, Inc.. (“Ocular” or the “Company”) (NASDAQ: OCUL) securities between May 5, 2017 and July 6, 2017, inclusive (the “Class Period”). Ocular investors have until September 5, 2017 to file a lead plaintiff motion.

Investors suffering losses on their Ocular investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com.

According to the Complaint filed in this class action, throughout the Class period, Ocular made materially false and misleading statements about the Company’s compliance, operational and business policies. Specifically, the complaint alleges that the Company issued false and/or misleading statements and/or failed to disclose that: (1) Ocular Therapeutix’s management has been misleading investors about DEXTENZA manufacturing issues, including that more than 50% of lots manufactured by Ocular Therapeutix contain bad product; (2) such manufacturing issues could imperil the approval of DEXTENZA by the FDA; and (3) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

If you purchased shares of Ocular during the Class Period you may move the Court no later than September 5, 2017 to ask the Court to appoint you as lead plaintiff if you meet certain legal requirements. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at http://www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

Recent Stories

RSS feed for Law Offices of Howard G. Smith

Release Summary

The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Ocular Therapeutix, Inc. Investors

Law Offices of Howard G. Smith